Veroniek M. Harbers
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Dupilumab in prurigo nodularis: 52-week effectiveness and safety from the prospective multicenter BioDay registry.
Journal: Journal of the American Academy of Dermatology
Published: March 20, 2026
Dupilumab in prurigo nodularis: 52-Week effectiveness and safety from the prospective multicenter BioDay registry.
Journal: Journal of the American Academy of Dermatology
Published: March 20, 2026
Dupilumab versus tralokinumab in atopic dermatitis: A propensity score adjusted comparison from BioDay.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 15, 2026
Magnitude and relevance of change in health-related quality of life in patients with vascular malformations treated with sirolimus.
Journal: Frontiers in medicine
Published: January 31, 2023
Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations - A nationwide trial.
Journal: Clinical and translational science
Published: June 27, 2022
Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.
Journal: British journal of clinical pharmacology
Published: October 13, 2021
Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus.
Journal: Advances in therapy
Published: March 22, 2021
Crushing of dolutegravir fixed-dose combination tablets increases dolutegravir exposure.
Journal: The Journal of antimicrobial chemotherapy
Published: February 28, 2018
A new paediatric formulation of valaciclovir: development and bioequivalence assessment.
Journal: Archives of disease in childhood
Published: April 20, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026